School of Medicine


Showing 3,841-3,850 of 4,929 Results

  • Clea Sarnquist, DrPH, MPH

    Clea Sarnquist, DrPH, MPH

    Clinical Professor, Pediatrics - Infectious Diseases

    BioDr. Sarnquist focuses on applied teaching and research on the development, implementation and evaluation of interventions to decrease gender-based violence and prevent HIV infection, especially among adolescents and children. She is particularly interested in rights-based approaches that tackle the complex interplay of factors that lead to poor health for many children and families. All of her work is applied, with direct links health practice and policy, and usually performed in conjunction with non-governmental organization and government partners. She works both globally and in the U.S., with a focus on sub-Saharan Africa. She is also a medical educator, directing the scholarly concentrations program of the pediatric residency at Stanford, and co-directing the global health concentration for residents

  • Frank Sarnquist

    Frank Sarnquist

    Professor of Anesthesia at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsMedical effects of heart bypass surgery; physiological, effects of high altitude; risk management in anesthesia; anesthesia, education.

  • Amir H. Sarrami

    Amir H. Sarrami

    Clinical Instructor, Radiology - Pediatric Radiology

    Current Research and Scholarly InterestsArtificial intelligence algorithms for PET/MRI in children with Lymphoma

  • Anuja Anand Sathe

    Anuja Anand Sathe

    Instructor, Medicine - Oncology

    Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.

  • Ansuman Satpathy

    Ansuman Satpathy

    Associate Professor of Pathology

    Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.

  • Neda Sattarnezhad Oskouei, MD, MS

    Neda Sattarnezhad Oskouei, MD, MS

    Instructor, Medicine - Immunology & Rheumatology

    BioDr. Neda Sattarnezhad Oskouei is a board-certified neurologist and neuroimmunologist specializing in Multiple Sclerosis (MS) and neuroimmunological disorders, including Neuromyelitis Optica (NMO), MOG Antibody Disease (MOGAD), optic neuritis, transverse myelitis, autoimmune encephalitis, neuro-rheumatological conditions, and neuroinfectious diseases. Her research focuses on understanding the role of pathogens in triggering autoimmunity, with a particular emphasis on the role of Epstein-Barr Virus (EBV) in the development of MS.

    Dr. Sattarnezhad earned her MD degree with honors from Tabriz University of Medical Sciences. She completed a research fellowship in Multiple Sclerosis at the Brigham MS Center, Harvard Medical School, before pursuing her residency in adult neurology at the University of Illinois at Chicago. She further specialized by completing a clinical fellowship in Multiple Sclerosis and Neuroimmunology at Stanford University as a Sylvia Lawry Fellow of the National MS Society, during which she also earned a master’s degree in Epidemiology and Clinical Research. She subsequently completed a fellowship in immunology and rheumatology at Stanford.

    Her research and training have been supported by the National MS Society (NMSS), National Institutes of Health (NIH), and National Institute of Allergy and Infectious Diseases (NIAID). Dr. Sattarnezhad is a member of the American Academy of Neurology (AAN) and the Consortium of Multiple Sclerosis Centers (CMSC).